Log in

CRTX CRISM Therapeutics Corporation LSE · British Virgin Islands

CRISM Therapeutics (CRTX) news

CRISM Therapeutics Corporation is a public biotech or pharmaceutical company listed on LSE under the ticker CRTX, recorded under British Virgin Islands. The directory classifies it as Oncology drug delivery. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest CRISM Therapeutics news

We have not published a story on CRISM Therapeutics yet. When there is news, it will appear here.

Questions about CRISM Therapeutics

What is the ticker symbol of CRISM Therapeutics?

CRISM Therapeutics Corporation trades under the ticker CRTX on LSE.

Where is CRISM Therapeutics listed?

CRISM Therapeutics Corporation is listed on LSE.

Which country or territory is CRISM Therapeutics listed under?

Our directory records CRISM Therapeutics Corporation under British Virgin Islands.

What does CRISM Therapeutics do?

Our directory classifies CRISM Therapeutics Corporation as: Oncology drug delivery. This is a directory classification, not a description of the pipeline.

What is the ISIN of CRISM Therapeutics?

The ISIN recorded for CRISM Therapeutics Corporation is VGG042401262.

Does aibio.space cover CRISM Therapeutics?

aibio.space lists CRISM Therapeutics Corporation among 2,820 public biotech companies and publishes its news here as stories appear.

Investor discussion: CRISM Therapeutics

Members talk about CRISM Therapeutics (CRTX). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open LSE:CRTX on TradingView.

Listing details

CRISM Therapeutics Corporation is a public biotech or pharmaceutical company listed on LSE under the ticker CRTX, recorded under British Virgin Islands. The directory classifies it as Oncology drug delivery. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
CRISM Therapeutics Corporation
Ticker
CRTX
Listing
LSE
Country or territory
British Virgin Islands
Business scope
Oncology drug delivery
ISIN
VGG042401262
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.